These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33167787)

  • 1. Time-dependent, dynamic prediction of fatty acid-binding protein 4, Galectin-3, and soluble ST2 measurement with poor outcome after acute stroke.
    Hansen C; Sastre C; Wolcott Z; Bevers MB; Kimberly WT
    Int J Stroke; 2021 Aug; 16(6):660-668. PubMed ID: 33167787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ST2 Predicts Poor Functional Outcome in Acute Ischemic Stroke Patients.
    Krishnamoorthy S; Singh G; Sreedharan SE; Damayanthi D; Gopala S; Madhusoodanan UK; Sylaja PN
    Cerebrovasc Dis Extra; 2023; 13(1):33-40. PubMed ID: 36754033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating FABP4 (Fatty Acid-Binding Protein 4) Is a Novel Prognostic Biomarker in Patients With Acute Ischemic Stroke.
    Tu WJ; Zeng XW; Deng A; Zhao SJ; Luo DZ; Ma GZ; Wang H; Liu Q
    Stroke; 2017 Jun; 48(6):1531-1538. PubMed ID: 28487339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Utility of Fatty Acid-Binding Protein 4 in Patients with Type 2 Diabetes and Acute Ischemic Stroke.
    Li S; Bi P; Zhao W; Lian Y; Zhu H; Xu D; Ding J; Wang Q; Yin C
    Neurotox Res; 2018 Feb; 33(2):309-315. PubMed ID: 28801883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.
    Polineni S; Parker DM; Alam SS; Thiessen-Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between serum adipocyte fatty acid-binding protein and 3-month disability outcome after aneurysmal subarachnoid hemorrhage.
    Luo YG; Han B; Sun TW; Liu X; Liu J; Zhang J
    J Neuroinflammation; 2020 Feb; 17(1):66. PubMed ID: 32075656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.
    Wolcott Z; Batra A; Bevers MB; Sastre C; Khoury J; Sperling M; Meyer BC; Walsh KB; Adeoye O; Broderick JP; Kimberly WT
    Ann Clin Transl Neurol; 2017 Aug; 4(8):553-563. PubMed ID: 28812045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of soluble ST2 but not galectin-3 are associated with increased risk of mortality in hemodialysis patients.
    Kim AJ; Ro H; Kim H; Ko KP; Chang JH; Lee HH; Chung W; Jung JY
    Kidney Res Clin Pract; 2021 Mar; 40(1):109-119. PubMed ID: 33706479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients.
    Wojciechowska C; Romuk E; Nowalany-Kozielska E; Jacheć W
    Hellenic J Cardiol; 2017; 58(5):350-359. PubMed ID: 28363768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy.
    Sharim J; Daniels LB
    Curr Cardiol Rep; 2020 May; 22(6):41. PubMed ID: 32430626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage.
    Yan XJ; Yu GF; Jie YQ; Fan XF; Huang Q; Dai WM
    J Neurol Sci; 2016 Sep; 368():121-7. PubMed ID: 27538613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke.
    Liu Y; Guo D; Wang A; Yang J; Zhu Z; Xu T; Zhong C; Peng H; Chen J; Zhou Y; Zhang Y; He J
    Clin Chim Acta; 2020 Dec; 511():33-39. PubMed ID: 32986993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke.
    Wang A; Zhong C; Zhu Z; Xu T; Peng Y; Xu T; Peng H; Chen CS; Wang J; Ju Z; Li Q; Geng D; Sun Y; Zhang J; Yuan X; Chen J; Zhang Y; He J
    Stroke; 2018 Jan; 49(1):211-214. PubMed ID: 29229724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
    Lupón J; Gaggin HK; de Antonio M; Domingo M; Galán A; Zamora E; Vila J; Peñafiel J; Urrutia A; Ferrer E; Vallejo N; Januzzi JL; Bayes-Genis A
    Int J Cardiol; 2015 Apr; 184():337-343. PubMed ID: 25734941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.